CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention

被引：9
作者：
Williams, Alexis K. [1 ]
Klein, Melissa D. [2 ]
Martin, Jesse [1 ]
Weck, Karen E. [4 ]
Rossi, Joseph S. [2 ,3 ]
Stouffer, George A. [2 ,3 ]
Lee, Craig R. [1 ,3 ]
机构：
[1] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Div Cardiol, Chapel Hill, NC USA
[3] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA
[4] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA
来源：
CIRCULATION-GENOMIC AND PRECISION MEDICINE | 2019年 / 12卷 / 02期
关键词：
cardiovascular diseases; clopidogrel; pharmacogenetics; precision medicine; IMPLEMENTATION;
D O I：
10.1161/CIRCGEN.119.002441
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：97 / 99
页数：3
相关论文
共 50 条
  • [31] Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent
    Sanchez-Ramos, Jesus
    Lucia Davila-Fajardo, Cristina
    Toledo Frias, Pablo
    Diaz Villamarin, Xando
    Javier Martinez-Gonzalez, Luis
    Martinez Huertas, Susana
    Burillo Gomez, Francisco
    Caballero Borrego, Juan
    Bautista Paves, Alicia
    Marin Guzman, Ma Carmen
    Ramirez Hernandez, Jose Antonio
    Correa Vilches, Concepcion
    Cabeza Barrera, Jose
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 : 289 - 295
  • [32] Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: Exploring the Role of Genotype-Guided Therapy in Reducing Readmission Rates
    Comanici, Maria
    Raja, Shahzad G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 203 : 507 - 508
  • [33] Impact of CYP2C19 Genetic Testing on Provider Prescribing Patterns for Antiplatelet Therapy After Acute Coronary Syndromes and Percutaneous Coronary Intervention
    Desai, Nihar R.
    Canestaro, William J.
    Kyrychenko, Pavlo
    Chaplin, Donald
    Martell, Lori A.
    Brennan, Troyen
    Matlin, Olga S.
    Choudhry, Niteesh K.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (06): : 694 - +
  • [34] Rates of 30-Day and 90-Day Readmission Between Genotype-Optimal and Genotype-Suboptimal Antiplatelet Therapy Prescribing After Percutaneous Coronary Intervention
    Cheng, Kevin K.
    San Andres, Christian
    Salam, Emen
    Han, Jin
    Lee, James C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 202 : 218 - 222
  • [35] CYP2C19 genotype-directed P2Y12 inhibitor antiplatelet therapy normalizes risk for major adverse cardiovascular events after percutaneous coronary intervention
    Stys, Tomasz P.
    Gedela, Maheedhar
    Gowda, Smitha N.
    Bares, Valerie
    Fanta, Lauren
    Petrasko, Marian
    Hajek, Catherine
    Larson, Eric
    Stys, Adam T.
    INDIAN HEART JOURNAL, 2021, 73 (03) : 281 - 288
  • [36] Financial Analysis of CYP2C19 Genotyping in Patients Receiving Dual Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention
    Johnson, Samuel G.
    Gruntowicz, Don
    Chua, Theresa
    Morlock, Robert J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (07) : 552 - 557
  • [37] Point of care CYP2C19 genotyping after percutaneous coronary intervention
    Baudhuin, Linnea M.
    Train, Laura J.
    Goodman, Shaun G.
    Lane, Gary E.
    Lennon, Ryan J.
    Mathew, Verghese
    Murthy, Vishakantha
    Nazif, Tamim M.
    So, Derek Y. F.
    Sweeney, John P.
    Wu, Alan H. B.
    Rihal, Charanjit S.
    Farkouh, Michael E.
    Pereira, Naveen L.
    PHARMACOGENOMICS JOURNAL, 2022, 22 (5-6) : 303 - 307
  • [38] Clinical Outcomes After Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms
    Zhang, Yang
    Zhao, Xiliang
    Ye, Yicong
    Li, Quan
    Zeng, Yong
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 183 - 191
  • [39] Attitudes toward pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention
    Lee, Grace
    Varughese, Lisa A.
    Conway, Laura
    Stojinski, Carol
    Ashokkumar, Sandhya
    Monono, Karen
    Matthai, William
    Kolansky, Daniel M.
    Giri, Jay
    Tuteja, Sony
    PERSONALIZED MEDICINE, 2021, 19 (02) : 93 - 101
  • [40] Precision Antiplatelet Therapy for CYP2C19 Genotype Variants for Achieving Better Clinical Outcomes
    Cha, Jung-Joon
    Lim, Do-Sun
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (13) : 1500 - 1501
12345